Table 3.
Non-responder analysis: Descriptive results and prevalence of atopic diseases, data taken from ISAAC Phase Two.
| % 95% CI1 |
Group 12 (n = 2581) |
Group 23 (n = 1767) |
Group 34 (n = 2051) |
|---|---|---|---|
| Female | 55.0 53.1; 56.9 |
53.8 51.5; 56.1 |
58.1 56.0; 60.3 |
| High parental level of education5 |
41.5 39.5; 43.5 |
47.1 44.7; 49.4 |
58.9 56.7; 61.0 |
| Smoking during pregnancy |
13.5 11.9; 15.1 |
9.8 8.3; 11.4 |
5.9 4.8; 7.0 |
| Passive smoke exposure | 50.3 48.3; 52.4 |
47.3 44.9; 49.7 |
36.4 34.3; 38.5 |
| Current wheeze6 |
6.9 5.9; 7.9 |
9.5 8.1; 10.8 |
8.2 7.0; 9.4 |
| Doctor diagnosed asthma | 3.3 2.6; 4.0 |
4.5 3.5; 5.5 |
3.4 2.6; 4.2 |
| Current allergic rhinitis7 |
11.1 9.8; 12.3 |
14.1 12.4; 15.7 |
14.4 12.8; 15.9 |
| Current atopic dermatitis8 |
11.6 10.4; 12.9 |
13.2 11.6; 14.8 |
15.2 13.6; 16.7 |
| Specific IgE > 0.7 kU/L |
28.7 26.0; 31.3 |
34.8 32.1; 37.4 |
33.4 31.0; 35.7 |
| Positive skin prick test | 23.2 21.0; 25.5 |
24.5 22.3; 26.7 |
23.6 21.7; 25.6 |
| Bronchial hyperreactivity | 14.7 11.9; 17.4 |
19.5 16.5; 22.4 |
17.3 14.8; 19.8 |
| Parental allergic disease9 |
36.2 34.3; 38.1 |
40.9 38.6; 43.3 |
46.2 44.0; 48.3 |
1 95% CI: 95% Confidence Interval
2 group 1: people who participated only in ISAAC Phase Two
3 group 2: people who participated in ISAAC Phase Two and SOLAR I
4 group 3: people who participated in SOLAR II (without the people of group 1 and 2)
5 at least one parent with a minimum of 12 years of education
6 wheezing in the last 12 months
7 problems with sneezing or a runny or blocked nose (without having a cold) accompanied by itchy-
watery eyes in the last 12 months
8 itching eczema in the last 12 months persisting at least 6 months
9 asthma, allergic rhinitis or atopic dermatitis
bold: statistically significant differences between groups